MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$230K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Common stock issued for consulti...
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Accrued expenses
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-952
-1,006
-893
-1,159
Depreciation
9
8
7
0
Change in fair value of warrant liability
0
-
0
0
Common stock issued for services rendered
-
85
208
174
Common stock issued for consulting services rendered, including board fees and salary
275
-
-
-
Stock-based compensation
57
56
35
127
Receivables
0
-3
3
-2
Prepaid expenses and other current assets
-129
-40
-202
-166
Accounts payable
330
-212
-230
34
Accrued expenses
-63
-5
122
-188
Net cash flows from operating activities
-300
-1,031
-552
-844
Purchases of property and equipment
-
-
1
97
Net cash flows from investing activities
-
-
-1
-97
Proceeds from the issuance of common stock and pre funded warrants, net of offering costs
0
-
0
0
Proceeds from sale of series a-1 preferred stock
0
-
0
0
Proceeds from sale of series a-2 preferred stock
0
-
0
0
Proceeds from equity line of credit, net of cost
70
-
-
-
Net cash flows from financing activities
70
-
0
0
Net increase (decrease) in cash, cash equivalents
-230
-1,031
-553
-941
Cash and cash equivalents, beginning of period
354
1,385
1,938
1,091
Cash and cash equivalents, end of period
124
354
1,385
1,938
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from equity line
of credit, net of...
$70K
Net cash flows from
financing activities
$70K
(-97.85%↓ Y/Y)
Net increase
(decrease) in cash, cash...
-$230K
(-112.86%↓ Y/Y)
Canceled cashflow
$70K
Accounts payable
$330K
(12.63%↑ Y/Y)
Common stock issued for
consulting services...
$275K
Prepaid expenses and
other current assets
-$129K
(-816.67%↓ Y/Y)
Stock-based compensation
$57K
(-77.38%↓ Y/Y)
Depreciation
$9K
Net cash flows from
operating activities
-$300K
(79.63%↑ Y/Y)
Canceled cashflow
$800K
Net loss
-$952K
(55.18%↑ Y/Y)
something is missing
-$85K
Accrued expenses
-$63K
(-170.00%↓ Y/Y)
Buy us a coffee
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT)